$1.72
-0.08-4.44%
At close: -
$1.79
0.074.07%
After Hours: Dec 23, 9:05 AM EDT
Comments
Loading...
Avenue Therapeutics (NASDAQ:ATXI) Stock, Earnings Estimates, EPS, And Revenue
Avenue Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 14
EPS
$-1.920
Quarterly Revenue
$0.00
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Avenue Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Avenue Therapeutics (ATXI) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-14 | $-1.92 | $-0.94 | -104.3 % |
| Jun 2024 | 2024-08-09 | $-6.43 | $-1.05 | -512.4 % |
| Mar 2024 | 2024-05-15 | $-15.40 | $-9.00 | -71.1 % |
| Dec 2023 | 2024-03-18 | $2.25 | $-7.50 | 130.0 % |
Avenue Therapeutics (ATXI) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Avenue Therapeutics (NASDAQ:ATXI) reporting earnings?
Avenue Therapeutics (ATXI) is scheduled to report earnings on March 17, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
What were the latest earnings per share (EPS) for Avenue Therapeutics (NASDAQ:ATXI)?
The Actual EPS was $-1.92, which missed the estimate of $-0.94.
What were Avenue Therapeutics’s (NASDAQ:ATXI) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.